GRAFT FAILURE
Clinical trials for GRAFT FAILURE explained in plain language.
Never miss a new study
Get alerted when new GRAFT FAILURE trials appear
Sign up with your email to follow new studies for GRAFT FAILURE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Common pill may save heart bypass grafts from failing
Disease control Recruiting nowThis study is testing if a low-dose colchicine pill, taken daily for a year, can help prevent the new blood vessel grafts from failing after coronary artery bypass graft (CABG) surgery. It will involve 100 adults who recently had successful bypass surgery. Researchers will use he…
Matched conditions: GRAFT FAILURE
Phase: PHASE4 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New hope to stop devastating transplant failure
Disease control Recruiting nowThis early study is testing whether a drug called emapalumab can prevent graft rejection in high-risk patients receiving stem cell transplants. Researchers believe blocking a specific immune signal (interferon gamma) might stop the body from rejecting the new cells. The trial wil…
Matched conditions: GRAFT FAILURE
Phase: EARLY_PHASE1 • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New transplant trial aims to free patients from lifelong blood transfusions
Disease control Recruiting nowThis study is testing a donor stem cell transplant to treat people with severe inherited blood disorders like sickle cell disease and thalassemia, who currently depend on regular blood transfusions. The goal is to replace the patient's faulty blood-making system with a healthy do…
Matched conditions: GRAFT FAILURE
Phase: PHASE2 • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Disease control
Last updated Mar 27, 2026 12:41 UTC
-
Heart surgery breakthrough: finding the best graft for women
Disease control Recruiting nowThis study compares two different blood vessel grafts used during heart bypass surgery in women. Researchers want to see whether using a vein from the leg (with a special 'no-touch' technique) or an artery from the arm works better for keeping blood flowing to the heart long-term…
Matched conditions: GRAFT FAILURE
Phase: NA • Sponsor: University of Sao Paulo General Hospital • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC
-
Second chance cells: new treatment tested for failing transplants
Disease control Recruiting nowThis study is testing a treatment called a 'donor cell boost' for adults whose stem cell transplants aren't working well or have failed. The goal is to help the patient's body rebuild healthy blood counts by giving them more specially selected cells from their original donor. Res…
Matched conditions: GRAFT FAILURE
Phase: NA • Sponsor: NYU Langone Health • Aim: Disease control
Last updated Mar 12, 2026 13:51 UTC